SCHEMBL14036696

SCHEMBL14036696

Cc1cc(OCCCl)c(C(C)C)cc1CN(C(=O)OC(C)(C)C)C1CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.38
SLC6A4 P31645 3/20 0.38
SLC6A3 Q01959 3/20 0.38
ADRA1D P25100 2/20 0.38
ADRA1A P35348 2/20 0.38
ADRA1B P35368 2/20 0.38
CYP1A2 P05177 1/20 0.38
ADRA2A P08913 1/20 0.38
CYP2D6 P10635 1/20 0.38
PKM P14618 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
HTR2C P28335 1/20 0.38
HRH1 P35367 1/20 0.38
DRD3 P35462 1/20 0.38
OPRK1 P41145 1/20 0.38
CHRNA4 P43681 1/20 0.38
HIF1A Q16665 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2805304 0.78 REN (0.44) NR1H4RENGAATSHRALDH1A1
SCHEMBL1072359 0.74 SLC6A4 (0.42) SLC6A2SLC6A4SLC6A3CYP2D6HTR2C
SCHEMBL662474 0.72 SLC6A2 (0.36) SLC6A2SLC6A4SLC6A3CYP2D6NR1H4
SCHEMBL18509018 0.71 REN (0.43) NR1H4RENGAATSHRALDH1A1
SCHEMBL662475 0.70 REN (0.44) NR1H4RENHTR2A
SCHEMBL2811860 0.69 REN (0.45) SLC6A2SLC6A4SLC6A3NR1H4REN
SCHEMBL661553 0.69 REN (0.38) SLC6A2SLC6A4SLC6A3CYP2D6NR1H4
SCHEMBL14036780 0.69 KDM4E (0.36) ADRA1DADRA1AADRA1BCYP1A2ADRA2A
SCHEMBL1518385 0.69 REN (0.47) REN
SCHEMBL13132250 0.69 REN (0.43) NR1H4REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008137102-A2 METHODS OF MODULATING AMYLOID BETA AND COMPOUNDS USEFUL THEREFOR TORREYPINES THERAPEUTICS, INC. (US) 2008-11-13 WO disclosed